Related Experiment Video

Updated: Aug 15, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Otitis media update: pathogenesis and treatment

G S Giebink1

  • 1Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis.

The Annals of Otology, Rhinology & Laryngology. Supplement
|January 1, 1992
PubMed

Insights

Acute otitis media, common in children, requires tailored antimicrobial treatment. While clinical responses vary, bacteriologic efficacy differs significantly, necessitating personalized approaches for effective otitis media management.

Area of Science:

  • Otolaryngology
  • Pediatrics
  • Infectious Diseases

Background:

  • Otitis media is a common childhood illness with potential long-term effects.
  • It encompasses a spectrum from acute to chronic infections.
  • Acute otitis media often follows viral respiratory infections with secondary bacterial involvement.

Purpose of the Study:

  • To analyze the management of acute otitis media.
  • To evaluate antimicrobial therapy effectiveness.
  • To highlight the need for personalized treatment strategies.

Main Methods:

  • Review of clinical manifestations and histopathologic changes in otitis media.
  • Analysis of antimicrobial therapy outcomes.
  • Assessment of bacteriologic efficacy of antimicrobial drugs.

Main Results:

  • Clinical response to various antimicrobials for acute otitis media is generally similar.
  • Bacteriologic efficacy of these antimicrobial drugs shows considerable variability.
  • Current empiric antimicrobial treatment for acute otitis media may not be optimal.

Conclusions:

  • Antimicrobial treatment for acute otitis media needs refinement.
  • Personalized treatment based on patient and disease factors is crucial.
  • Addressing variability in bacteriologic efficacy is key for improved outcomes.

More Related Videos

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma02:37

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma

Published on: December 15, 2023

Techniques of Endoscopic Ossiculoplasty09:07

Techniques of Endoscopic Ossiculoplasty

Published on: January 26, 2024

Related Concept Videos

Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...